Stimuli‐Responsive Metal Complexes for Biomedical Applications
Authors:
- 1 September 2022
- journal article
- review article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 61 (40) , e202205900
Abstract
Metal‐based compounds have been widely used for biomedical applications. Their unique characteristics make them attractive for both therapeutic and diagnostic purposes. However, numerous issues including toxicity, poor aqueous solubility, and unfavorable biodistribution hamper their widespread use. To overcome these drawbacks, the concept of metal‐based prodrugs emerged. This field is particularly developed for applications in oncology. More precisely, tumor‐associated stimuli (e.g., pH variation, redox activity, enzyme overexpression, etc.) have been exploited to trigger the selective delivery of active metal‐based drugs to the tumor site. The main advances in this area are discussed in this Review.Keywords
Funding Information
- H2020 European Research Council (681679)
- Agence Nationale de la Recherche (ANR-10-IDEX-0001-02 PSL)
- Ligue Contre le Cancer
This publication has 111 references indexed in Scilit:
- Aminoferrocene-Based Prodrugs and Their Effects on Human Normal and Cancer Cells as Well as Bacterial CellsJournal of Medicinal Chemistry, 2013
- Glutathione Transferase (GST)-Activated ProdrugsPharmaceutics, 2013
- Simple and Real-Time Colorimetric Assay for Glycosidases Activity Using Functionalized Gold Nanoparticles and Its Application for Inhibitor ScreeningAnalytical Chemistry, 2012
- Redox activation of metal-based prodrugs as a strategy for drug deliveryAdvanced Drug Delivery Reviews, 2012
- Conjugation of Organoruthenium(II) 3-(1H-Benzimidazol-2-yl)pyrazolo[3,4-b]pyridines and Indolo[3,2-d]benzazepines to Recombinant Human Serum Albumin: a Strategy To Enhance Cytotoxicity in Cancer CellsInorganic Chemistry, 2011
- Lipoplatin Formulation Review ArticleJournal of Drug Delivery, 2011
- Gadolinium-based cancer therapeutic liposomes for chemotherapeutics and diagnosticsColloids and Surfaces B: Biointerfaces, 2011
- Mechanism-Based Tumor-Targeting Drug Delivery System. Validation of Efficient Vitamin Receptor-Mediated Endocytosis and Drug ReleaseBioconjugate Chemistry, 2010
- Current applications and future potential for bioinorganic chemistry in the development of anticancer drugsDrug Discovery Today, 2009
- Receptor mediated uptake of a radiolabeled contrast agent sensitive to β-galactosidase activityNuclear Medicine and Biology, 2003